AOD-9604 10mg

AOD9604 Peptide is the research community's shorthand for AOD-9604 - the same compound listed on this page. If you searched for AOD9604 Peptide, AOD9604, HGH Frag, hGH Fragment 176-191, this is that compound: AOD-9604 supplied as a 10mg lyophilised vial, third-party tested with a batch-specific Certificate of Analysis. For in-vitro research use only.

AOD-9604 is a synthetic peptide supplied by Pillar Research as Lyophilised powder for lawful in-vitro laboratory research under the Research Use Only (RUO) framework. In research communities it is also searched for as AOD9604, HGH Frag, hGH Fragment 176-191 - all refer to the same compound.

Studied for how a fragment of growth hormone behaves apart from the full molecule. More precisely, a fragment covering residues 176-191 - studied as an isolated lipolytic fragment, not as full-length growth hormone. AOD-9604 is supplied strictly as Research Use Only material for in-vitro laboratory work.

Studied for how fat metabolism behaves in laboratory models. More precisely, fat-metabolism research and weight-management study contexts, reflecting its research use as an isolated lipolytic fragment of growth hormone.

AOD-9604 is commonly referred to as AOD9604 Peptide in research communities and is sometimes searched for as AOD9604, HGH Frag, hGH Fragment 176-191 - all refer to the same compound.

AOD-9604 is a fragment of human growth hormone covering residues 176-191 (the "hGH fragment" or "HGH frag" research-community shorthand) - it is not full-length growth hormone.

You are looking at the evidence the same way researchers do: by compound, batch and method, not by marketing claim. AOD-9604 is supplied as a research-use compound for lawful in-vitro laboratory research under the Research Use Only (RUO) framework. Each Pillar Research batch is third-party tested by HPLC and mass spectrometry, with the batch-specific Certificate of Analysis published for review before ordering - that certificate is the research record to judge.

Pillar Research does not provide dosing, reconstitution-for-use, or administration guidance for any compound - this is a deliberate policy, not an oversight, consistent with the Research Use Only framework under which AOD-9604 is supplied. Research protocols vary by study design and institution. Consult the peer-reviewed literature for the compound (see the references linked on this page) or a qualified research supervisor for protocol-specific guidance.

AOD-9604 (10mg) is available through Pillar Research, a trusted supplier for research peptides, with fast domestic shipping to all states and territories. Every vial is dispatched from domestic Australian stock the same business day - no customs delays, no international freight uncertainty. The batch-specific Certificate of Analysis is available to review before ordering. See our supplier guide at /buy-peptides-australia for the checklist to apply to any Australian supplier.

Pillar Research does. Each AOD-9604 batch is tested by Janoshik Analytical, an independent third-party laboratory, and the batch-specific Certificate of Analysis is published on this page before you order. Stock is held in Australia and dispatched with dispatch in an estimated 1-2 weeks.

AOD-9604 (10mg) is priced at A$89.99 per vial at Pillar Research. AOD-9604 is open for preorder now. Orders dispatch in an estimated 1-2 weeks. Batch Certificates of Analysis are available in our CoA library.

AOD-9604 is a research-use compound supplied for lawful in-vitro laboratory research under the Research Use Only (RUO) framework. Purchasers confirm the compound is intended for in-vitro research use at checkout.

Ordering is straightforward - add AOD-9604 10mg (AOD9604 Peptide) to your cart on this page and complete checkout. All orders are fulfilled from domestic Australian stock and shipped with tracking; dispatch in an estimated 1-2 weeks. A batch-specific Certificate of Analysis is included with every order.

Yes. Each released AOD-9604 10mg (AOD9604 Peptide) vial is linked to a batch-specific Certificate of Analysis (COA) so the stated purity, identity and batch record can be reviewed before ordering. AOD-9604 10mg (AOD9604 Peptide) is listed at 99.504% purity. Each released batch is independently analysed by HPLC for chromatographic purity and by mass spectrometry for identity.

AOD-9604 is a fragment of human growth hormone covering residues 176-191 - studied as an isolated lipolytic fragment, not as full-length growth hormone and not through the growth-hormone receptor pathway. Pillar Research supplies AOD-9604 strictly as Research Use Only material for in-vitro laboratory work.

No. AOD-9604 is not listed on the Australian Register of Therapeutic Goods (ARTG), so it is not stocked by Australian retail pharmacies and is not a therapeutic good under the Therapeutic Goods Act 1989 (Cth). Compounding pharmacies cannot supply it either - there is no approved commercial or pharmacy release to compound from. Pillar Research supplies it as Research Use Only material for in-vitro laboratory work, not for human or animal use, and it should not be sought as a consumer product.

AOD-9604 may be lawfully supplied and held in Australia as Research Use Only material for in-vitro laboratory and educational research. That is a different status from approval for human use, which it does not have. Purchasers confirm they are a qualified researcher or acting for a licensed research facility, and are responsible for the lawful handling, storage and use of the material.